Your browser doesn't support javascript.
loading
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemia.
Tanaka, Atsushi; Nakano, Taizo A; Nomura, Masaki; Yamazaki, Hiromi; Bewersdorf, Jan P; Mulet-Lazaro, Roger; Hogg, Simon; Liu, Bo; Penson, Alex; Yokoyama, Akihiko; Zang, Weijia; Havermans, Marije; Koizumi, Miho; Hayashi, Yasutaka; Cho, Hana; Kanai, Akinori; Lee, Stanley C; Xiao, Muran; Koike, Yui; Zhang, Yifan; Fukumoto, Miki; Aoyama, Yumi; Konuma, Tsuyoshi; Kunimoto, Hiroyoshi; Inaba, Toshiya; Nakajima, Hideaki; Honda, Hiroaki; Kawamoto, Hiroshi; Delwel, Ruud; Abdel-Wahab, Omar; Inoue, Daichi.
Afiliação
  • Tanaka A; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Nakano TA; Laboratory of Immunology, Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.
  • Nomura M; Department of Pediatrics, Section of Hematology, Oncology and Bone Marrow Transplantation, University of Colorado, Aurora, CO.
  • Yamazaki H; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Bewersdorf JP; Facility for iPS Cell Therapy, CiRA Foundation, Kyoto, Japan.
  • Mulet-Lazaro R; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Hogg S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Liu B; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Penson A; Oncode Institute, Utrecht, The Netherlands.
  • Yokoyama A; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Zang W; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Havermans M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Koizumi M; Tsuruoka Metabolomics Laboratory, National Cancer Center, Yamagata, Japan.
  • Hayashi Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Cho H; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Kanai A; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
  • Lee SC; Oncode Institute, Utrecht, The Netherlands.
  • Xiao M; Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Koike Y; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Zhang Y; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, United States.
  • Fukumoto M; Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Aoyama Y; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Chiba, Japan.
  • Konuma T; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
  • Kunimoto H; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA.
  • Inaba T; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Nakajima H; Division of Cellular Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Honda H; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Kawamoto H; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Delwel R; Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Abdel-Wahab O; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
  • Inoue D; Department of Hematology-Oncology, Institute of Biomedical Research and Innovation, Foundation for Biomedical Research and Innovation at Kobe, Kobe, Hyogo, Japan.
Blood ; 140(8): 875-888, 2022 08 25.
Article em En | MEDLINE | ID: mdl-35709354
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proto-Oncogenes / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proto-Oncogenes / Leucemia Mieloide Aguda Idioma: En Ano de publicação: 2022 Tipo de documento: Article